The company has received a Notice of Allowance from the United States Patent and Trademark Office for the patent application no. 14/903,032, “Use of a Fluidic Device”.
The patent application covers the proprietary minimum inhibitory concentration (MIC) determination of a bacterial sample within a microfluidic controlled environment that is part of the technology platform of the company’s diagnostic system QuickMIC for ultra-rapid antibiotic susceptibility testing (AST).
A Notice of Allowance signifies that Gradientech will be entitled to receive patent protection until at least 2034 in the United States for the allowed claims when the patent is issued. Gradientech has already been granted patent protection for MIC determination in Europe, Japan and China.